Over the past 100 years, the updation and iteration of different insulin types and the emergence and application of new hypoglycemic drugs such as GLP-1 receptor agonists have significantly improved the awareness, diagnosis, treatment, and control rate of T2DM. Here, INS is linked to type 2 diabetes mellitus.